Table 4.

Association between liver enzymes and hypertension among study groups

Hypertension
	OR (95%CI)	P value	Adjusted OR (95%CI)	P value
AST
1st (≤ 18)	Reference		Reference
2nd (19–23)	1.11(1.02–1.21)	0.009	1.09(0.98–1.21)	0.106
3rd (≥ 24)	1.24(1.14–1.35)	< 0.001	1.22(1.09–1.37)	< 0.001
ALT
1st (≤ 18)	Reference		Reference
2nd (19–26)	1.35(1.25–1.47)	< 0.001	1.14(1.02–1.28)	0.015
3rd (≥ 27)	1.55(1.42–1.69)	< 0.001	1.51(1.35–1.70)	< 0.001
ALP
1st (≤ 160)	Reference		Reference
2nd (161–206)	1.34(1.23–1.46)	< 0.001	1.08(0.97–1.21)	0.14
3rd (≥ 207)	1.82(1.67–1.98)	< 0.001	1.19(1.07–1.34)	0.001
GGT
1st (≤ 16)	Reference		Reference
2nd (17–25)	1.57(1.44–1.71)	< 0.001	1.37(1.22–1.54)	< 0.001
3rd (≥ 26)	1.97(1.81–2.15)	< 0.001	1.68(1.49–1.89)	< 0.001

Adjusted for age, gender, BMI, WSI (socioeconomic status), Physical activity (MET), and hypertension treatments, BMI, waist circumference, Diabetes, Prediabetes

Aspartate aminotransferase, ALT; Alanine aminotransferase, GGT; Gamma-glutamyl transferase, ALP; Alkaline phosphatase